Table 3.
Study | Country | Breed2 | Study design | Groups compared (length of dam- calf contact) | n (animals) | Number of herds | Diagnostic | Conclusion | |
---|---|---|---|---|---|---|---|---|---|
Berghaus et al., 2005 | United States | Not specified | Risk assessment questionnaire paired with clinical case reports (data from United States National Animal Health Monitoring System) | Frequency with which calves are permitted to nurse on farm (continuous variable) | Not applicable | 815 | (Clinical case reports) | Reports of clinical JD less likely in herds that allowed calves to nurse the dam | + |
Collins et al., 1994 | United States | Not specified | Latency to dam-calf separation evaluated as a risk factor and paired with results from cross-sectional blood samples | Separation time categorized as <1, 1 to 8, or >8 h | 4,990 | 158 | Serum ELISA | Herd MAP3 prevalence not associated with calf-dam separation time | = |
Cetinkaya et al., 1997 | England | Varied | Producers surveyed on duration of cow-calf contact in combination with an assessment of clinical case reports | Separation time categorized as 0, 1 to 10, or >10 d | Not applicable | 2,9154 | (Clinical case reports) | No association between disease risk and duration calves are kept with the dam | = |
Johnson- Ifearulundu and Kaneene, 1998 | United States | Not specified | Latency to dam-calf separation evaluated as a risk factor and paired with results from cross-sectional blood samples | Not specified (likely a continuous variable) | Not specified | 121 | Serum ELISA | Number of hours before dam-calf separation not associated with herd MAP infection status | = |
Wells and Wagner, 2000 | United States | Not specified | Data from United States National Animal Health Monitoring System assessed based upon latency to dam-calf separation | Separation time categorized as <24 or ≥24 h | 32,622 | 1,004 | Serum ELISA | Latency to cow-calf separation not associated with a current JD diagnosis | = |
Ridge et al., 2005 | Australia | Not specified | Latency to dam-calf separation evaluated as a risk factor in relation to results from the voluntary JD testing program | Separation time categorized as <12, 12–24, or >24 h | Cows >2 yr tested annually | 54 | Unspecified ELISA | Time before calf removal had no relationship to JD control | = |
Ansari- Lari et al., 2009 | Iran | HF and HF crossbreeds | Risk factors for MAP-positive bulk tanks evaluated, including whether the calf spent ≥3 h with the dam | Separation time categorized as <3 or ≥3 h | Not specified | 110 | Bulk-milk PCR | No association between herd infection status and calves spending ≥3 h with dam PR (95% CI)5 = 0.91 (0.13–6.33) | = |
Dieguez et al., 2008 | Spain | HF | Latency to dam-calf separation evaluated as a risk factor and paired with results from cross-sectional blood samples | Separation time categorized as before or after colostrum feeding | 5,528 | 101 | Serum ELISA | Separating the calf after colostrum feeding not associated with herd infection status PR (95% CI) = 0.79 (0.13–4.94) (“positive” and “highly positive” herds considered together) | = |
Tavornpanich et al., 2008 | United States | HF and Jersey | Early separation of calf and dam evaluated based upon whether herds had a high MAP prevalence | Separation time categorized as 1 to 6 vs. >6 h | 1,260 | 21 | Serum ELISA | Late calf separation not associated with high MAP prevalence PR (95% CI) = 0.57 (0.16–2.06) | = |
Norton et al., 2009 | New Zealand | HF and Jersey6 | Average duration of dam-calf contact evaluated in relation to self-reports of clinical JD | Separation time categorized as <12, 12 to 24, or >24 h (not specified if categories were used in analysis) | Not applicable | 427 | (Clinical case reports) | Average duration of dam-calf contact not associated with incidence of clinical JD | = |
Correia-Gomes et al., 2010 | Portugal | Not specified | Latency to dam-calf separation evaluated as a risk factor of herd MAP status | Separation time categorized as ≤ 6, 7 to 12, or >12 h | 5,294 | 122 | Milk ELISA | Hours cow and calf are together not associated with herd MAP status. Crude OR (95% CI)7 with ≤6 h as reference = 1.26 (0.72–2.21) for 7–12 h and 1.40 (0.50–3.93) for >12 h | = |
Nielsen and Toft, 2011 | Denmark | Not specified | Longitudinal (4.25 yr) blood samples analyzed alongside the practice of separating calves from high-risk dams within 2 h | Separation time categorized as ≤2 or >2 h | All lactating cows | 97 | Milk ELISA | Removal of calves from high risk dams not associated with decreased MAP prevalence | = |
Donat et al., 2016 | Germany | HF | Average latency of cow-calf separation evaluated as a risk factor and paired with data from longitudinal (5 yr) fecal sampling | Not specified | All cows | 28 | Fecal culture | Latency of cow-calf separation not associated with cumulative herd-level incidence of MAP shedders | = |
Pillars et al., 2011 | United States | HF and Jersey | Longitudinal (5 yr) blood and fecal samples analyzed and assessed relative to time spent with the dam (including nursing) | Risk scores (1–10) assigned based upon time spent with dam (<30 min to >24 h) and nursing the dam (never to always) | 3,707 | 7 | Serum ELISA, fecal culture, or both | Nursing and time spent with the dam were risk factors associated with JD positive cows at the univariable but not multivariable stage | −/= |
Listed for each study are country, breed of cattle, study design, groups compared (in reference to length of cow-calf contact), total number of animals sampled, number of herds included, the diagnostic test implemented, and the authors' conclusion and direction of effect (with + signifying a beneficial effect of suckling or cow-calf contact, − signifying a negative effect, and = representing no difference. Studies are ordered by effect direction, then chronologically by year, then alphabetically within year).
HF signifies that breed was reported as Holstein, Friesian, or Holstein-Friesian. This designation includes country-specific variants such as Danish Holstein.
MAP = Mycobacterium avium ssp. paratuberculosis, the etiological agent of Johne's disease.
Sample size obtained from Cetinkaya et al., 1998.
PR (CI) = prevalence ratio (95% CI).
Predominantly.
OR (CI) = odds ratio (95% CI).